Budesonide 1 mg orodispersible tablets (BUL 1 mg) ( DrugBank: Budesonide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
98	好酸球性消化管疾患	2

98. 好酸球性消化管疾患

臨床試験数 : 171 / 薬物数 : 184 - (DrugBank : 47) / 標的遺伝子数 : 42 - 標的パスウェイ数 : 141

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-001314-37-AT (EUCTR)	06/05/2021	01/03/2021	clinical study to show equal clinical efficacy of two dosing regimen of budesonid orodispersible tab ...	Double-blind, double-dummy, randomized, parallel-group, non-inferiority phase III trial on the effic ...	eosinophilic esophagitis MedDRA version: 20.1;Level: PT;Classification code 10064212;Term: Eosinophi ...	Product Name: Budesonide 2 mg orodispersible tablets (BUL 2 mg) INN or Proposed INN: BUDESONIDE Trade ...	Dr. Falk Pharma GmbH	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	242	Phase 3	Portugal;Canada;Spain;Austria;Russian Federation;Germany;Switzerland
2	EUCTR2020-001314-37-DE (EUCTR)	26/04/2021	27/11/2020	clinical study to show equal clinical efficacy of two dosing regimen of budesonid orodispersible tab ...	Double-blind, double-dummy, randomized, parallel-group, non-inferiority phase III trial on the effic ...	eosinophilic esophagitis MedDRA version: 20.1;Level: PT;Classification code 10064212;Term: Eosinophi ...	Product Name: Budesonide 2 mg orodispersible tablets (BUL 2 mg) INN or Proposed INN: BUDESONIDE Trade ...	Dr. Falk Pharma GmbH	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	242	Phase 3	Portugal;Canada;Spain;Austria;Russian Federation;Germany;Switzerland

First Previous1Next Last